Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28,736,767
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
26,718,966
-
Shares change
-
+26,718,966
-
Total reported value, excl. options
-
$9,627,559
-
Value change
-
+$9,627,559
-
Number of buys
-
2
-
Price
-
$0.3627
Significant Holders of GeneDx Holdings Corp. - Common Stock (WGS) as of Q1 2023
2 filings reported holding WGS - GeneDx Holdings Corp. - Common Stock as of Q1 2023.
GeneDx Holdings Corp. - Common Stock (WGS) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26,718,966 shares
of 28,736,767 outstanding shares and own 93% of the company stock.
Largest 2 shareholders include MARSHALL WACE, LLP (25,118,221 shares) and PRICE T ROWE ASSOCIATES INC /MD/ (1,600,745 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.